Buscar
SIGA Technologies Inc
SIGAAñadir a la lista de seguimiento
3.150USD
+0.120+3.96%
Cierre 09-14 16:00（ET）
225.59MCap. mercado
11.10P/E TTM
Más Datos de SIGA Technologies Inc Compañía
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.
Perfil de SIGA Technologies Inc
Símbolo de cotizaciónSIGA
Nombre de la empresaSIGA Technologies Inc
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoNguyen (Diem)
Número de empleados46
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 09
Dirección31 East 62Nd Street
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10065
Teléfono12126729100
Sitio Webhttps://www.siga.com/
Símbolo de cotizaciónSIGA
Fecha de salida a bolsaSep 09, 1997
Director ejecutivoNguyen (Diem)
Ejecutivos de SIGA Technologies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
73.75K
+22.89%
Mr. Julian Nemirovsky
Mr. Julian Nemirovsky
Independent Director
Independent Director
73.75K
+22.89%
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
16.88K
--
Gen. (Retd.) John M. (Jack) Keane
Gen. (Retd.) John M. (Jack) Keane
Independent Director
Independent Director
16.88K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Mr. Daniel J. Luckshire
Mr. Daniel J. Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Chief Financial Officer, Executive Vice President, Corporate Secretary
280.49K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Dennis E. Hruby, Ph.D.
Dr. Dennis E. Hruby, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
198.54K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Dr. Diem Nguyen, Ph.D.
Dr. Diem Nguyen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
138.77K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de SIGA Technologies Inc?
Los cinco principales accionistas de SIGA Technologies Inc son: Mr. Daniel J. Luckshire
¿Cuántas instituciones poseen acciones de SIGA Technologies Inc (SIGA)?
A fecha de 2026Q1, 396 instituciones poseen acciones de SIGA Technologies Inc, con un valor de mercado combinado de aproximadamente 39.67M, lo que representa el 55.31% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 319822.00.